These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 21459893)
1. Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma. Huang J; Duan Q; Fan P; Ji C; Lv Y; Lin X; Qian L; Yu X Cell Biochem Biophys; 2011 Mar; 59(2):127-32. PubMed ID: 20963512 [TBL] [Abstract][Full Text] [Related]
2. New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma. Liu H; Wang C; Wang R; Cao H; Cao Y; Huang T; Lu Z; Xiao H; Hu M; Wang H; Zhao J Chin J Cancer Res; 2024 Apr; 36(2):167-194. PubMed ID: 38751435 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization. Lin LW; Ke K; Yan LY; Chen R; Huang JY Front Oncol; 2023; 13():1178428. PubMed ID: 37207144 [TBL] [Abstract][Full Text] [Related]
4. Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence. Zhang S; Wang WS; Zhong BY; Ni CF J Clin Transl Hepatol; 2022 Aug; 10(4):740-747. PubMed ID: 36062280 [TBL] [Abstract][Full Text] [Related]
5. Severe Colitis Caused by Hepatic Arterial Infusion Chemotherapy with Cisplatin for Hepatocellular Carcinoma. Yamamoto S; Onishi H; Oyama A; Takaki A; Okada H Intern Med; 2020 Jan; 59(1):69-75. PubMed ID: 31484909 [TBL] [Abstract][Full Text] [Related]
6. Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients. Moriya K; Namisaki T; Sato S; Furukawa M; Douhara A; Kawaratani H; Kaji K; Shimozato N; Sawada Y; Saikawa S; Takaya H; Kitagawa K; Akahane T; Mitoro A; Yamao J; Yoshiji H Clin Mol Hepatol; 2019 Dec; 25(4):381-389. PubMed ID: 31405269 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study. Wu J; Li A; Yang J; Lu Y; Li J Onco Targets Ther; 2017; 10():2761-2768. PubMed ID: 28603426 [TBL] [Abstract][Full Text] [Related]
10. Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values. Zheng DX; Meng SC; Liu QJ; Li CT; Shang XD; Zhu YS; Bai TJ; Xu SM World J Gastroenterol; 2016 Mar; 22(10):3031-7. PubMed ID: 26973399 [TBL] [Abstract][Full Text] [Related]
11. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas. Yamakado K; Hirota S World J Gastroenterol; 2015 Oct; 21(37):10604-8. PubMed ID: 26457020 [TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study. Takaki H; Yamakado K; Tsurusaki M; Yasumoto T; Baba Y; Narimatsu Y; Shimohira M; Yamaguchi M; Matsuo K; Inaba Y; Mikami K; Watanabe R; Nishida N; Anai H; Kakizawa H; Hirota S Int J Clin Oncol; 2015 Aug; 20(4):745-54. PubMed ID: 25432660 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. Miyahara K; Nouso K; Yamamoto K World J Gastroenterol; 2014 Apr; 20(15):4151-9. PubMed ID: 24764653 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Ikeda M; Mitsunaga S; Shimizu S; Ohno I; Takahashi H; Okuyama H; Kuwahara A; Kondo S; Morizane C; Ueno H; Satake M; Arai Y; Okusaka T J Gastroenterol; 2014 May; 49(5):932-40. PubMed ID: 23793266 [TBL] [Abstract][Full Text] [Related]
15. Complete remission by transarterial infusion with cisplatin for recurrent bile duct tumor thrombus of hepatocellular carcinoma: report of a case. Ebara C; Yamazaki S; Moriguchi M; Mitsuka Y; Funada T; Higaki T; Takayama T World J Surg Oncol; 2013 Mar; 11():78. PubMed ID: 23521831 [TBL] [Abstract][Full Text] [Related]
16. Current status of hepatocellular carcinoma treatment in Japan: case study and discussion-voting system. Kudo M; Tateishi R; Yamashita T; Ikeda M; Furuse J; Ikeda K; Kokudo N; Izumi N; Matsui O Clin Drug Investig; 2012 Aug; 32 Suppl 2():37-51. PubMed ID: 22873626 [TBL] [Abstract][Full Text] [Related]
17. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893 [TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC. Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma]. Usui T; Shiozawa S; Kim DH; Tsuchiya A; Masuda T; Inose S; Aizawa M; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K Gan To Kagaku Ryoho; 2010 Nov; 37(12):2702-4. PubMed ID: 21224685 [TBL] [Abstract][Full Text] [Related]